The shares of Marathon Patent Group, Inc. (NASDAQ:MARA) started off the last trading session with the price of $1.6 while closing the day with the price of $2.43. The shares of Marathon Patent Group, Inc. (NASDAQ:MARA) Rise 58.67% with the Gain of 0.83 points.
The shares of Marathon Patent Group, Inc. (NASDAQ:MARA) traded with the day volume of 14.24 Million shares whereas its average trading volume is 2.57 Million.
While analyzing the past performance of the stock we can see that the shares of Marathon Patent Group, Inc. (NASDAQ:MARA) Gain 17.39% in the last week while Falling -5.08% in the last month. Past quarter performance shows the red light with -46.94%. The semi-annual and annual performance shows 39.66% and -53.98% respectively.
Some critical values of the shares of Marathon Patent Group, Inc. (NASDAQ:MARA) to be discussed here are: the beta which shows the value at 2.05 while Average True Range of Marathon Patent Group, Inc. (NASDAQ:MARA) demonstrate the value at 0.3. The weekly and monthly volatility of the shares of Marathon Patent Group, Inc. (NASDAQ:MARA) are indicated at 20.33% and 12.12%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 49.43.
While studying the financial position of the shares of Marathon Patent Group, Inc. (NASDAQ:MARA), we can see that the Market capitalization of the company is at 33.49 Million. The shares outstanding for the company is 13.78 Million and the shares float stands at 10.13 Million. The income of the company stand at -38900000 while the sales stand at 800000.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -8.86, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 41.86, the Return on Asset ROA stood at -2.638 and the Return on Equity ROE depicted at 3.871 while Return on Investment ROI is at -2.657.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) started its previous trading session at $5.07 and closed at $5.06 showing a Fell of -0.59 Percent.
The Company traded with an average Volume of 1.9 Million whereas, its Day Volume stood at 590146.
Looking at the performance of the stock, HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Gain 16.06% in the last week in its shares price and 50.15% in the last month. Quarterly performance shows a green of 167.72 Percent while Semi-Annual and Annual performances shows a 169.15 and 122.32 percent respectively.
Beta for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) stands at 0 while the ATR (average true range) is at 0.5. The Stock’s Weekly and Monthly Volatility is 10.92% and 13.37% respectively showing a RSI value of 60.59.
While studying the financial position of the shares of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), we can see that the Market capitalization of the company is at 145.83 Million. The shares outstanding for the company is 28.82 Million and the shares float stands at 25.07 Million.
The Company generated an income of -22700000 and the sales of 8.3 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.55 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 17.57 respectively.
The Return on Assets stands at -1.362, ROE shows a value of 4.016 and ROI for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is -1.645 as of Trailing Twelve Months period.
